1 INDICATIONS AND USAGE
Piperacillin and tazobactam for injection, USP is a combination of piperacillin, a penicillin-class antibacterial and tazobactam, a beta-lactamase inhibitor, indicated for the treatment of:
Intra-abdominal infections in adult and pediatric patients 2 months of age and older (
1.1)
Nosocomial pneumonia in adult and pediatric patients 2 months of age and older (
1.2)
Skin and skin structure infections in adults (
1.3)
Female pelvic infections in adults (
1.4)
Community-acquired pneumonia in adults (
1.5)
To reduce the development of drug-resistant bacteria and maintain the effectiveness of piperacillin and tazobactam for injection and other antibacterial drugs, piperacillin and tazobactam for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. (
1.6)
1.1 Intra-abdominal Infections
Piperacillin and tazobactam for injection, USP is indicated in adults and pediatric patients (2 months of age and older) for the treatment of appendicitis (complicated by rupture or abscess) and peritonitis caused by beta-lactamase producing isolates of
Escherichia coli or the following members of the
Bacteroides fragilis group:
B. fragilis,
B. ovatus,
B. thetaiotaomicron, or
B. vulgatus.
1.2 Nosocomial Pneumonia
Piperacillin and tazobactam for injection, USP is indicated in adults and pediatric patients (2 months of age and older) for the treatment of nosocomial pneumonia (moderate to severe) caused by beta-lactamase producing isolates of
Staphylococcus aureus and by piperacillin/tazobactam-susceptible
Acinetobacter baumannii,
Haemophilus influenzae,
Klebsiella pneumoniae, and
Pseudomonas aeruginosa (Nosocomial pneumonia caused by
P. aeruginosa should be treated in combination with an aminoglycoside)
[see
Dosage and Administration (2)
].
1.3 Skin and Skin Structure Infections
Piperacillin and tazobactam for injection, USP is indicated in adults for the treatment of uncomplicated and complicated skin and skin structure infections, including cellulitis, cutaneous abscesses and ischemic/diabetic foot infections caused by beta-lactamase producing isolates of
Staphylococcus aureus.
1.4 Female Pelvic Infections
Piperacillin and tazobactam for injection, USP is indicated in adults for the treatment of postpartum endometritis or pelvic inflammatory disease caused by beta-lactamase producing isolates of
Escherichia coli.
1.5 Community-acquired Pneumonia
Piperacillin and tazobactam for injection, USP is indicated in adults for the treatment of community-acquired pneumonia (moderate severity only) caused by beta-lactamase producing isolates of
Haemophilus influenzae.
1.6 Usage
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Piperacillin and tazobactam for injection, USP and other antibacterial drugs, Piperacillin and tazobactam for injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.